1. The growing world of CAR T cell trials: a systematic review

   • Astrid Holzinger
   • Markus Barden
   • Hinrich Abken

   Review 09 September 2016 Pages: 1433 - 1450

   

2. Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

   • Mariëtte I. E. van Poelgeest
   • Valeria V. Visconti
   • Marij J. P. Welters

   Original Article Open access 12 September 2016 Pages: 1451 - 1463

   

3. Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma

   • Sarah Maria Johler
   • Jörg Fuchs
   • Sorin Armeanu-Ebinger

   Original Article 15 September 2016 Pages: 1465 - 1476

   

4. Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

   • Toshiko Kamata
   • Akane Suzuki
   • Shinichiro Motohashi

   Original Article Open access 15 September 2016 Pages: 1477 - 1489

   

5. Anti-PD-1 inhibits Foxp3⁺ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model

   • Lydia Dyck
   • Mieszko M. Wilk
   • Kingston H. G. Mills

   Original Article 28 September 2016 Pages: 1491 - 1498

   

6. Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma

   • Yasuharu Akasaki
   • Tetsuro Kikuchi
   • Yuichi Murayama

   Original Article 29 September 2016 Pages: 1499 - 1509

   

7. Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models

   • Emily A. Lanzel
   • M. Paula Gomez Hernandez
   • Kim A. Brogden

   Original Article 29 September 2016 Pages: 1511 - 1522

   

8. Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2

   • Wei Wang
   • Amy K. Erbe
   • Paul M. Sondel

   Original Article 30 September 2016 Pages: 1523 - 1532

   

9. Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma

   • Ajjai Alva
   • Gregory A. Daniels
   • Janice P. Dutcher

   Original Article Open access 06 October 2016 Pages: 1533 - 1544

   

10. Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models

    • Anning Li
    • Yue Wu
    • John W. Chen

    Original Article 08 October 2016 Pages: 1545 - 1554

    

11. Anti-GITR therapy promotes immunity against malignant glioma in a murine model

    • Jason Miska
    • Aida Rashidi
    • Maciej S. Lesniak

    Original Article 12 October 2016 Pages: 1555 - 1567